Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Vitale A, Caggiano V, Sbalchiero J, Lopalco G, Tufan A, Ragab G, Sfikakis PP, Dagna L, Batu ED, Ozen S, Conti F, Maiolini F, Bugatti S, Frassi M, Ruscitti P, Cito A, Cakir IY, Akay N, Konte EK, Laskari K, Emreol HE, Priori R, Croce J, De Stefano L, Francesca C, Cipriani P, La Torre F, Maggio MC, Al-Mayouf SM, Fotis L, Rigante D, Verrecchia E, Guggino G, La Barbera L, Piga M, Emmi G, Gallizzi R, Conti G, Sfriso P, Bartoloni E, Giacomelli R, Barone P, Gicchino MF, Alemanno A, Lo Gullo A, Direskeneli H, Alibaz-Oner F, Karamanakos A, Prete M, Edrees A, Gavioli F, Parronchi P, Ciccia F, Cardamone C, Hernández-Rodríguez J, Hatemi G, Bes C, Almaghlouth IA, Marhuenda ÁR, Gonzáles-García A, Gaggiano C, Mormile I, Tezcan ME, Brucato AL, Feist E, Tornero-Romero F, Suzon B, Ogunjimi B, Thabet M, Conforti A, Pucino V, Boyarchuk O, Kovalchuk T, Govoni M, Iagnocco A, Chimenti MS, Moshrif A, Giudice ED, Carubbi F, Erten Ş, Tharwat S, Hegazy MT, Więsik-Szewczyk E, Torres-Ruiz J, Martín-Nares E, Balistreri A, Fabiani C, Frediani B, Hinojosa-Azaola A, Kasapçopur Ö, Cantarini L

Open source

DOI
10.1016/j.semarthrit.2026.153030
Published
2026 Oct
Container
Seminars in arthritis and rheumatism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.semarthrit.2026.153030,
  title = {Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.},
  author = {Vitale A and Caggiano V and Sbalchiero J and Lopalco G and Tufan A and Ragab G and Sfikakis PP and Dagna L and Batu ED and Ozen S and Conti F and Maiolini F and Bugatti S and Frassi M and Ruscitti P and Cito A and Cakir IY and Akay N and Konte EK and Laskari K and Emreol HE and Priori R and Croce J and De Stefano L and Francesca C and Cipriani P and La Torre F and Maggio MC and Al-Mayouf SM and Fotis L and Rigante D and Verrecchia E and Guggino G and La Barbera L and Piga M and Emmi G and Gallizzi R and Conti G and Sfriso P and Bartoloni E and Giacomelli R and Barone P and Gicchino MF and Alemanno A and Lo Gullo A and Direskeneli H and Alibaz-Oner F and Karamanakos A and Prete M and Edrees A and Gavioli F and Parronchi P and Ciccia F and Cardamone C and Hernández-Rodríguez J and Hatemi G and Bes C and Almaghlouth IA and Marhuenda ÁR and Gonzáles-García A and Gaggiano C and Mormile I and Tezcan ME and Brucato AL and Feist E and Tornero-Romero F and Suzon B and Ogunjimi B and Thabet M and Conforti A and Pucino V and Boyarchuk O and Kovalchuk T and Govoni M and Iagnocco A and Chimenti MS and Moshrif A and Giudice ED and Carubbi F and Erten Ş and Tharwat S and Hegazy MT and Więsik-Szewczyk E and Torres-Ruiz J and Martín-Nares E and Balistreri A and Fabiani C and Frediani B and Hinojosa-Azaola A and Kasapçopur Ö and Cantarini L},
  year = {2026},
  journal = {Seminars in arthritis and rheumatism},
  doi = {10.1016/j.semarthrit.2026.153030},
  url = {https://doi.org/10.1016/j.semarthrit.2026.153030}
}

RIS

TY  - JOUR
TI  - Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.
AU  - Vitale A
AU  - Caggiano V
AU  - Sbalchiero J
AU  - Lopalco G
AU  - Tufan A
AU  - Ragab G
AU  - Sfikakis PP
AU  - Dagna L
AU  - Batu ED
AU  - Ozen S
AU  - Conti F
AU  - Maiolini F
AU  - Bugatti S
AU  - Frassi M
AU  - Ruscitti P
AU  - Cito A
AU  - Cakir IY
AU  - Akay N
AU  - Konte EK
AU  - Laskari K
AU  - Emreol HE
AU  - Priori R
AU  - Croce J
AU  - De Stefano L
AU  - Francesca C
AU  - Cipriani P
AU  - La Torre F
AU  - Maggio MC
AU  - Al-Mayouf SM
AU  - Fotis L
AU  - Rigante D
AU  - Verrecchia E
AU  - Guggino G
AU  - La Barbera L
AU  - Piga M
AU  - Emmi G
AU  - Gallizzi R
AU  - Conti G
AU  - Sfriso P
AU  - Bartoloni E
AU  - Giacomelli R
AU  - Barone P
AU  - Gicchino MF
AU  - Alemanno A
AU  - Lo Gullo A
AU  - Direskeneli H
AU  - Alibaz-Oner F
AU  - Karamanakos A
AU  - Prete M
AU  - Edrees A
AU  - Gavioli F
AU  - Parronchi P
AU  - Ciccia F
AU  - Cardamone C
AU  - Hernández-Rodríguez J
AU  - Hatemi G
AU  - Bes C
AU  - Almaghlouth IA
AU  - Marhuenda ÁR
AU  - Gonzáles-García A
AU  - Gaggiano C
AU  - Mormile I
AU  - Tezcan ME
AU  - Brucato AL
AU  - Feist E
AU  - Tornero-Romero F
AU  - Suzon B
AU  - Ogunjimi B
AU  - Thabet M
AU  - Conforti A
AU  - Pucino V
AU  - Boyarchuk O
AU  - Kovalchuk T
AU  - Govoni M
AU  - Iagnocco A
AU  - Chimenti MS
AU  - Moshrif A
AU  - Giudice ED
AU  - Carubbi F
AU  - Erten Ş
AU  - Tharwat S
AU  - Hegazy MT
AU  - Więsik-Szewczyk E
AU  - Torres-Ruiz J
AU  - Martín-Nares E
AU  - Balistreri A
AU  - Fabiani C
AU  - Frediani B
AU  - Hinojosa-Azaola A
AU  - Kasapçopur Ö
AU  - Cantarini L
PY  - 2026
JO  - Seminars in arthritis and rheumatism
DO  - 10.1016/j.semarthrit.2026.153030
UR  - https://doi.org/10.1016/j.semarthrit.2026.153030
ER  -

APA

A, V., V, C., J, S., G, L., A, T., G, R., PP, S., L, D., ED, B., S, O., F, C., F, M., S, B., M, F., P, R., A, C., IY, C., N, A., EK, K., K, L., HE, E., R, P., J, C., L, D. S., C, F., P, C., F, L. T., MC, M., SM, A., L, F., D, R., E, V., G, G., L, L. B., M, P., G, E., R, G., G, C., P, S., E, B., R, G., P, B., MF, G., A, A., A, L. G., H, D., F, A., A, K., M, P., A, E., F, G., P, P., F, C., C, C., J, H., G, H., C, B., IA, A., ÁR, M., A, G., C, G., I, M., ME, T., AL, B., E, F., F, T., B, S., B, O., M, T., A, C., V, P., O, B., T, K., M, G., A, I., MS, C., A, M., ED, G., F, C., Ş, E., S, T., MT, H., E, W., J, T., E, M., A, B., C, F., B, F., A, H., Ö, K., & L, C. (2026). Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.. Seminars in arthritis and rheumatism. https://doi.org/10.1016/j.semarthrit.2026.153030

Source records